Holen Sie sich die Stockscreener-App
1.80
11.80%
0.19
Handel nachbörslich:
1.84
0.04
+2.22%
Schlusskurs vom Vortag:
$1.61
Offen:
$1.63
24-Stunden-Volumen:
496.71K
Relative Volume:
0.93
Marktkapitalisierung:
$7.39M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.1805
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
+24.14%
1M Leistung:
+28.57%
6M Leistung:
-44.79%
1J Leistung:
-62.50%
1-Tages-Spanne:
$1.58
$1.83
1-Wochen-Bereich:
$1.46
$1.83
52-Wochen-Spanne:
$1.215
$12.45
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Vergleichen Sie SXTP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.80 | 6.61M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
Institutional scanner results for 60 Degrees Pharmaceuticals Inc. Equity WarrantMarket Weekly Review & Accurate Technical Buy Alerts - newser.com
Using data models to predict 60 Degrees Pharmaceuticals Inc. stock movement2025 Market Overview & Smart Investment Allocation Insights - newser.com
Price momentum metrics for 60 Degrees Pharmaceuticals Inc. Equity Warrant explainedJuly 2025 WrapUp & Advanced Swing Trade Entry Plans - newser.com
Measuring 60 Degrees Pharmaceuticals Inc.’s beta against major indicesPortfolio Value Summary & Daily Volume Surge Signals - newser.com
Is 60 Degrees Pharmaceuticals Inc a good long term investmentAnalyst Downgrades & Minimal Investment Capital Gains - earlytimes.in
60 Degrees Pharmaceuticals Inc. stock chart pattern explainedTrade Risk Assessment & Community Verified Trade Signals - newser.com
60 Degrees Pharmaceuticals Inc. stock volume spike explainedAnalyst Downgrade & Low Risk Profit Maximizing Plans - newser.com
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant outperform the marketTrade Ideas & High Accuracy Swing Entry Alerts - newser.com
Will 60 Degrees Pharmaceuticals Inc. stock attract more institutional investorsInsider Buying & Accurate Entry/Exit Alerts - newser.com
How institutional ownership impacts 60 Degrees Pharmaceuticals Inc. stock2025 AllTime Highs & High Accuracy Swing Trade Signals - newser.com
What machine learning models say about 60 Degrees Pharmaceuticals Inc.2025 Major Catalysts & High Accuracy Trade Alerts - newser.com
Can trapped investors hope for a rebound in 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Fed Impact & Daily Stock Trend Reports - newser.com
Live market analysis of 60 Degrees Pharmaceuticals Inc.Bond Market & Fast Gain Swing Trade Alerts - newser.com
Is 60 Degrees Pharmaceuticals Inc. stock oversold or undervaluedMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Predicting 60 Degrees Pharmaceuticals Inc. Equity Warrant trend using moving averagesWeekly Trend Recap & Verified Short-Term Plans - newser.com
Live market analysis of 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Investor Takeaways & Expert Approved Momentum Ideas - newser.com
What high frequency data says about 60 Degrees Pharmaceuticals Inc.Quarterly Risk Review & Weekly Top Gainers Alerts - newser.com
Detecting support and resistance levels for 60 Degrees Pharmaceuticals Inc. Equity WarrantQuarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Top chart patterns to watch in 60 Degrees Pharmaceuticals Inc.Quarterly Growth Report & Daily Momentum Trading Reports - newser.com
Join 60 Degrees Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on October 22 - The Daily Jeffersonian
Is it time to cut losses on 60 Degrees Pharmaceuticals Inc.2025 Dividend Review & Community Driven Trade Alerts - newser.com
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Canton Repository
60 Degrees Pharmaceuticals stockholders approve board, equity plan amendment and reverse split - Investing.com Canada
60 Degrees Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Visual trend scoring systems applied to 60 Degrees Pharmaceuticals Inc.2025 Dividend Review & Short-Term High Return Ideas - newser.com
Can 60 Degrees Pharmaceuticals Inc. stock sustain market leadershipStop Loss & Free AI Powered Buy and Sell Recommendations - newser.com
How buybacks impact 60 Degrees Pharmaceuticals Inc. stock valueJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
60 Degrees Pharmaceuticals Inc-Aktie (SXTP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):